Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 16334-16335 [2014-06452]
Download as PDF
<![CDATA[
16334
Federal Register / Vol. 79, No. 57 / Tuesday, March 25, 2014 / Notices
in, an entity is required to provide their
Data Universal Numbering System
(DUNS) number. FSRS then pulls core
data about the entity from their System
for Award Management (SAM)
registration to include the legal business
name, physical address, mailing address
and Commercial and Government Entity
(CAGE) code. The entity completes the
FSRS registration by providing contact
information within the entity for
approval.
If a prime awardee has already
registered in FSRS to report contractsrelated Transparency Act financial data,
a new log-in will not be required. In
addition, if a prime awardee had a user
account in the Electronic Subcontract
Reporting System (eSRS), a new log-in
will not be required.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC)
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Subcommittee on Procedures Review,
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Respondents: 1,844.
Responses Per Respondent: 1.
Total annual responses: 1,844.
Hours Per Response: .5.
Total Burden Hours: 922.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW., Washington, DC
20405, telephone 202–501–4755. Please
cite OMB Control No. 3090–0291, FSRS
Registration Requirements for Prime
Grant Awardees, in all correspondence.
Times and Dates: 9:00 a.m.–5:00 p.m.,
April 10, 2014.
9:00 a.m.–12:00 p.m., April 11, 2014.
Place: CDC Global Communications
Center, Building 19, Auditorium B3, 1600
Clifton Road NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Director, Division of Healthcare Quality
Promotion, the Director, National Center for
Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, the Secretary,
Health and Human Services regarding (1) the
practice of healthcare infection prevention
and control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of CDC guidelines and
other policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda will
include updates on the Draft Guideline to
Prevent Surgical Site Infections, CDC and
Division of Healthcare Quality Promotion’s
(DHQP’s) activities for prevention and
surveillance of healthcare associated
infections (HAI), core infection prevention
and control practices and the Draft Health
Care Personnel guideline.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, 1600
Clifton Road, NE., Mailstop A–07, Atlanta,
Georgia 30333 Telephone (404) 639–4045.
Email: hicpac@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: March 18, 2014.
Sonny Hashmi,
Deputy Chief Information Officer, Office of
the Deputy CIO.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–06555 Filed 3–24–14; 8:45 am]
[FR Doc. 2014–06455 Filed 3–24–14; 8:45 am]
BILLING CODE 6820–XY–P
BILLING CODE 4163–18–P
B. Public Comments
Public comments are particularly
invited on: Whether this collection of
information is necessary for the proper
performance of functions of the FSRS
Registration Requirements for Prime
Grant Awardees, whether it will have
practical utility; whether our estimate of
the public burden of this collection of
information is accurate, and based on
valid assumptions and methodology;
ways to enhance the quality, utility, and
clarity of the information to be
collected; and ways in which we can
minimize the burden of the collection of
information on those who are to
respond, through the use of appropriate
technological collection techniques or
other forms of information technology.
A 60-day notice, requesting comments
was published in the Federal Register at
78 FR 79454 on December 30, 2013, no
comments were received.
C. Annual Reporting Burden
emcdonald on DSK67QTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
18:16 Mar 24, 2014
Jkt 232001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned subcommittee:
Time And Date: 11:00 a.m.–5:00 p.m., EST,
April 16, 2014.
Place: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 and the pass
code is 9933701.
Status: Open to the public. The public is
welcome to submit written comments in
advance of the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included in
the official record of the meeting. The public
is also welcome to listen to the meeting by
joining the teleconference at the USA tollfree, dial-in number, 1–866–659–0537 and
the passcode is 9933701.
Background: The ABRWH was established
under the Energy Employees Occupational
Illness Compensation Program Act of 2000 to
advise the President on a variety of policy
and technical functions required to
implement and effectively manage the
compensation program. Key functions of the
ABRWH include providing advice on the
development of probability of causation
guidelines that have been promulgated by the
Department of Health and Human Services
(HHS) as a final rule; advice on methods of
dose reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2015.
Purpose: The ABRWH is charged with (a)
providing advice to the Secretary, HHS, on
the development of guidelines under
Executive Order 13179; (b) providing advice
to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction
efforts performed for this program; and (c)
upon request by the Secretary, HHS,
providing advice to the Secretary on whether
there is a class of employees at any
Department of Energy facility who were
E:\FR\FM\25MRN1.SGM
25MRN1
Federal Register / Vol. 79, No. 57 / Tuesday, March 25, 2014 / Notices
emcdonald on DSK67QTVN1PROD with NOTICES
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is a reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee on Procedures
Review was established to aid the ABRWH in
carrying out its duty to advise the Secretary,
HHS, on dose reconstructions. The
Subcommittee on Procedures Review is
responsible for overseeing, tracking, and
participating in the reviews of all procedures
used in the dose reconstruction process by
the NIOSH Division of Compensation
Analysis and Support (DCAS) and its dose
reconstruction contractor (Oak Ridge
Associated Universities—ORAU).
Matters For Discussion: The agenda for the
Subcommittee meeting includes: discussion
of procedures in the following ORAU and
DCAS technical documents: ORAU Team
Technical Information Bulletin (OTIB)0034
(‘‘Internal Dose Coworker Data for X–10’’),
OTIB 0054 (‘‘Fission and Activation Product
Assignment for Internal Dose-Related Gross
Beta and Gross Gamma Analyses’’), OTIB
0083 (‘‘Dissolution Models for Insoluble
Plutonium 238’’), Program Evaluation Report
(PER) 011 (‘‘K–25 [Technical Basis
Document] TBD and TIB Revisions’’), PER
020 (‘‘Blockson TBD Revision’’), PER 031
(‘‘Y–12 TBD Revisions’’), PER 033
(‘‘Reduction Pilot Plant TBD Revision’’), PER
038 (‘‘Hooker Electrochemical TBD
Revisions’’); Update on Review of ORAU
Team Report 0053 (‘‘Stratified Co-Worker
Sets’’); discussion of estimating radiation
doses associated with localized skin
exposures to uranium at Atomic Weapons
Employer facilities; and a continuation of the
comment-resolution process for other dose
reconstruction procedures under review by
the Subcommittee.
The agenda is subject to change as
priorities dictate.
Contact Person For More Information:
Theodore Katz, Designated Federal Officer,
NIOSH, CDC, 1600 Clifton Road NE.,
Mailstop E–20, Atlanta Georgia 30333,
Telephone (513) 533–6800, Toll Free
1(800)CDC–INFO, Email ocas@cdc.gov. The
Director, Management Analysis and Services
Office, has been delegated the authority to
sign Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
16335
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control; Special
Emphasis Panel (SEP): Initial Review
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Research Approaches to
Improve the Care and Outcomes of
People Living with Spina Bifida, FOA
DD14–002, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
The meeting announced below
concerns A Creutzfeldt-Jakob Disease
(CJD) Lookback Study: Assessing the
Risk of Blood Borne Transmission of
Classic Forms of Creutzfeldt-Jakob
Disease, Funding Opportunity
Announcement (FOA) CK14–005, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates: 9:00 a.m.–6:00 p.m.,
April 14, 2014 (Closed).
9:00 a.m.–6:00 p.m., April 15, 2014
(Closed).
9:00 a.m.–6:00 p.m., April 16, 2014
(Closed).
9:00 a.m.–6:00 p.m., April 17, 2014
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters For Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Research Approaches to
Improve the Care and Outcomes of People
Living with Spina Bifida, FOA DD14–002,
initial review.’’
Contact Person For More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Time And Date: 2:00 p.m.–3:30 p.m., EST,
April 15, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters For Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘A Creutzfeldt-Jakob Disease
(CJD) Lookback Study: Assessing the Risk of
Blood Borne Transmission of Classic Forms
of Creutzfeldt-Jakob Disease, FOA CK14–005,
initial review.’’
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 718–8833.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–06451 Filed 3–24–14; 8:45 am]
BILLING CODE 4163–18–P
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–06450 Filed 3–24–14; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
[FR Doc. 2014–06452 Filed 3–24–14; 8:45 am]
Disease, Disability, and Injury
Prevention and Control; Special
Emphasis Panel (SEP): Initial Review
BILLING CODE 4163–18–P
The meeting announced below
concerns Grants for Injury Control
VerDate Mar<15>2010
18:16 Mar 24, 2014
Jkt 232001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 79, Number 57 (Tuesday, March 25, 2014)]
[Notices]
[Pages 16334-16335]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-06452]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Subcommittee on Procedures Review, Advisory Board on Radiation
and Worker Health (ABRWH or Advisory Board), National Institute for
Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
subcommittee:
Time And Date: 11:00 a.m.-5:00 p.m., EST, April 16, 2014.
Place: Audio Conference Call via FTS Conferencing. The USA toll-
free, dial-in number is 1-866-659-0537 and the pass code is 9933701.
Status: Open to the public. The public is welcome to submit
written comments in advance of the meeting, to the contact person
below. Written comments received in advance of the meeting will be
included in the official record of the meeting. The public is also
welcome to listen to the meeting by joining the teleconference at
the USA toll-free, dial-in number, 1-866-659-0537 and the passcode
is 9933701.
Background: The ABRWH was established under the Energy Employees
Occupational Illness Compensation Program Act of 2000 to advise the
President on a variety of policy and technical functions required to
implement and effectively manage the compensation program. Key
functions of the ABRWH include providing advice on the development
of probability of causation guidelines that have been promulgated by
the Department of Health and Human Services (HHS) as a final rule;
advice on methods of dose reconstruction which have also been
promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice
on petitions to add classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2015.
Purpose: The ABRWH is charged with (a) providing advice to the
Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary,
HHS, providing advice to the Secretary on whether there is a class
of employees at any Department of Energy facility who were
[[Page 16335]]
exposed to radiation but for whom it is not feasible to estimate
their radiation dose, and on whether there is a reasonable
likelihood that such radiation doses may have endangered the health
of members of this class. The Subcommittee on Procedures Review was
established to aid the ABRWH in carrying out its duty to advise the
Secretary, HHS, on dose reconstructions. The Subcommittee on
Procedures Review is responsible for overseeing, tracking, and
participating in the reviews of all procedures used in the dose
reconstruction process by the NIOSH Division of Compensation
Analysis and Support (DCAS) and its dose reconstruction contractor
(Oak Ridge Associated Universities--ORAU).
Matters For Discussion: The agenda for the Subcommittee meeting
includes: discussion of procedures in the following ORAU and DCAS
technical documents: ORAU Team Technical Information Bulletin
(OTIB)0034 (``Internal Dose Coworker Data for X-10''), OTIB 0054
(``Fission and Activation Product Assignment for Internal Dose-
Related Gross Beta and Gross Gamma Analyses''), OTIB 0083
(``Dissolution Models for Insoluble Plutonium 238''), Program
Evaluation Report (PER) 011 (``K-25 [Technical Basis Document] TBD
and TIB Revisions''), PER 020 (``Blockson TBD Revision''), PER 031
(``Y-12 TBD Revisions''), PER 033 (``Reduction Pilot Plant TBD
Revision''), PER 038 (``Hooker Electrochemical TBD Revisions'');
Update on Review of ORAU Team Report 0053 (``Stratified Co-Worker
Sets''); discussion of estimating radiation doses associated with
localized skin exposures to uranium at Atomic Weapons Employer
facilities; and a continuation of the comment-resolution process for
other dose reconstruction procedures under review by the
Subcommittee.
The agenda is subject to change as priorities dictate.
Contact Person For More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20,
Atlanta Georgia 30333, Telephone (513) 533-6800, Toll Free
1(800)CDC-INFO, Email ocas@cdc.gov. The Director, Management
Analysis and Services Office, has been delegated the authority to
sign Federal Register notices pertaining to announcements of
meetings and other committee management activities, for both the
Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-06452 Filed 3-24-14; 8:45 am]
BILLING CODE 4163-18-P
